NCT05087979 is a NA clinical trial of Stable airway management (SAM) device in Anesthesia, sponsored by Virginia Commonwealth University.

Who is sponsoring NCT05087979?

NCT05087979 is sponsored by Virginia Commonwealth University.

What drugs are being tested in NCT05087979?

Interventions in NCT05087979: Stable airway management (SAM) device.

What condition does NCT05087979 study?

NCT05087979 studies Anesthesia.

Is NCT05087979 still recruiting?

NCT05087979 is currently completed. Last updated 8 April 2024.

Are results published for NCT05087979?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2024-04-08 · How we verify

NCT05087979

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Use of Stable Airway Management Device in Monitored Anesthesia Care

Completed NA Results posted Last updated 8 April 2024

What this trial tests

NA trial testing Stable airway management (SAM) device in Anesthesia in 40 participants. Completed in 29 September 2022.

Timeline

28 July 2022

Primary endpoint
29 September 2022

29 September 2022

Quick facts

Lead sponsor	Virginia Commonwealth University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	40
Start date	28 July 2022
Primary completion	29 September 2022
Estimated completion	29 September 2022
Sites	1 location across United States

Drugs / interventions tested

Stable airway management (SAM) device

Conditions studied

Anesthesia — all drugs for Anesthesia →

Sponsor

Virginia Commonwealth University

Who can join

18 and older, any sex, with Anesthesia. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Total Apneic Events /Total Number Requiring Airway Manipulation Primary · Up to 6 hours

total number of apneic events greater than 20 seconds per 15-minute intervals, requiring airway manipulation - The median value of airway manipulations will be reported for each arm, along with the range of manipulations (low-high) for each study arm will be reported.

Group	Value	95% CI
Intervention	2	0 – 10
Standard of Care	1	0 – 11

Number of Subjects Converted From MAC to General Anesthesia Primary · Up to 6 hours

Number of participants converted from MAC to general anesthesia for airway-related complications

Group	Value	95% CI
Intervention	1
Standard of Care	0

Sponsor's own description

The aim of this study is to determine if the Stable Airway Management device (SAM) is safe in maintaining the airway in a stable, non-obstructing position during anesthetic cases requiring monitored anesthesia care (MAC).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Anesthesia

Currently open trials in the same condition.

NCT07294092 — Ketamine and Propofol NeuroImaging · EARLY_PHASE1 · recruiting
NCT07290205 — Remimazolam NeuroImaging · EARLY_PHASE1 · recruiting
NCT07465185 — Intrathecal Bupivacaine With or Without Dexmetomidine for Cesserian Delivery · Phase 2 · recruiting
NCT07269808 — Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration · Phase 3 · recruiting
NCT07443254 — Prospective IR-led Sedation Feasibility · Phase 1, PHASE2 · recruiting

Other Virginia Commonwealth University trials

Trials by the same sponsor.

NCT05936931 — Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening · NA · not yet recruiting
NCT07365839 — Cemiplimab +/- Fianlimab Post Y90 Radioembolization in Patients With Hepatocellular Carcinoma · Phase 1 · not yet recruiting
NCT07178158 — Enhancing Addiction Treatment Through Psychoeducation · NA · not yet recruiting
NCT07531316 — Safety and Tolerability Study of VVZ-2471 in Healthy Volunteers · Phase 1 · not yet recruiting
NCT07426913 — Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05087979 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Virginia Commonwealth University
Last refreshed: 8 April 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05087979.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing